SHARE PURCHASE AGREEMENTShare Purchase Agreement • April 14th, 2021 • Alimera Sciences Inc • Pharmaceutical preparations • Delaware
Contract Type FiledApril 14th, 2021 Company Industry JurisdictionTHIS SHARE PURCHASE AGREEMENT (this “Agreement”) is made as of April 14, 2021, by and between Ocumension Therapeutics, incorporated in the Cayman Islands with limited liability (“Investor”), and Alimera Sciences, Inc., a Delaware corporation (the “Company”).
OCUMENSION THERAPEUTICS (as Issuer) and ALIMERA SCIENCES, INC. (as Subscriber) WARRANT SUBSCRIPTION AGREEMENTWarrant Subscription Agreement • April 14th, 2021 • Alimera Sciences Inc • Pharmaceutical preparations • Hong Kong
Contract Type FiledApril 14th, 2021 Company Industry Jurisdiction(1)OCUMENSION THERAPEUTICS (歐康維視生物), a company incorporated under the laws of the Cayman Islands with limited liability having its registered office at P.O. Box 31119 Grand Pavilion, Hibiscus Way, 802 West Bay Road, Grand Cayman, KY1-1205, Cayman Islands, which shares have been listed on the Main Board of the Stock Exchange (HKEX: 1477) (the “Issuer”); and
EXCLUSIVE LICENSE AGREEMENTExclusive License Agreement • April 14th, 2021 • Alimera Sciences Inc • Pharmaceutical preparations
Contract Type FiledApril 14th, 2021 Company IndustryThis Exclusive License Agreement (this “Agreement”), dated as of April 14, 2021 (“Effective Date”), is by and between Alimera Sciences, Inc., a company organized and existing under the laws of the State of Delaware, United States of America (“Alimera”), and Ocumension (Hong Kong) Limited, a company organized and existing under the laws of Hong Kong (“Ocumension”). Alimera and Ocumension are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”
VOTING AND INVESTOR RIGHTS AGREEMENTVoting and Investor Rights Agreement • April 14th, 2021 • Alimera Sciences Inc • Pharmaceutical preparations • Delaware
Contract Type FiledApril 14th, 2021 Company Industry JurisdictionThis Voting and Investor Rights Agreement (this “Agreement”) is entered into as of April 14, 2021, by and between Alimera Sciences, Inc., a Delaware corporation (the “Company”), and Ocumension Therapeutics, incorporated in the Cayman Islands with limited liability (“Investor”). Unless otherwise provided, each capitalized term used and not otherwise defined herein shall have the meaning set forth in Article III.